Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Transplantation. 2020 Feb;104(2):349-356. doi: 10.1097/TP.0000000000002779.
Given the potential utility of frailty, a clinical phenotype of decreased physiologic reserve and resistance to stressors, to predict postkidney transplant (KT) outcomes, we sought to understand the perceptions and practices regarding frailty measurement in US KT programs.
Surveys were emailed to American Society of Transplantation Kidney/Pancreas Community of Practice members and 202 US transplant programs (November 2017 to April 2018). Program characteristics were gleaned from Scientific Registry of Transplant Recipients.
The 133 responding programs (response rate = 66%) represented 77% of adult KTs and 79% of adult KT candidates in the United States. Respondents considered frailty to be a useful concept in evaluating candidacy (99%) and endorsed a need to develop a frailty measurement specific to KT (92%). Frailty measurement was more common during candidacy evaluation (69%) than during KT admission (28%). Of the 202 programs, 38% performed frailty assessments in all candidates while 23% performed assessments only for older candidates. There was heterogeneity in the frailty assessment method; 18 different tools were utilized to measure frailty. The most common tool was a timed walk test (19%); 67% reported performing >1 tool. Among programs that measure frailty, 53% reported being less likely to list frail patients for KT.
Among US KT programs, frailty is recognized as a clinically relevant construct and is commonly measured at evaluation. However, there is considerable heterogeneity in the tools used to measure frailty. Efforts to identify optimal measurement of frailty using either an existing or a novel tool and subsequent standardization of its measurement and application across KT programs should be considered.
鉴于脆弱性的潜在效用,即生理储备和对压力源抵抗力降低的临床表型,它可用于预测肾移植(KT)后的结果,我们试图了解美国 KT 项目中测量脆弱性的看法和实践。
我们向美国移植学会肾脏/胰腺实践社区成员和 202 个美国移植项目发送了电子邮件调查(2017 年 11 月至 2018 年 4 月)。从移植受者科学登记处获取项目特征。
133 个回复项目(回复率=66%)代表了美国 77%的成人 KT 和 79%的成人 KT 候选者。受访者认为脆弱性在评估候选资格时是一个有用的概念(99%),并支持开发专门用于 KT 的脆弱性测量方法(92%)。脆弱性测量在候选者评估期间(69%)比 KT 入院期间(28%)更为常见。在 202 个项目中,38%对所有候选者进行脆弱性评估,而 23%仅对老年候选者进行评估。脆弱性评估方法存在异质性;使用了 18 种不同的工具来测量脆弱性。最常用的工具是计时步行测试(19%);67%的项目报告使用了>1 种工具。在进行脆弱性测量的项目中,53%的项目报告说,他们不太可能将虚弱的患者列入 KT 名单。
在美国 KT 项目中,脆弱性被认为是一个具有临床相关性的概念,并且在评估时通常会进行测量。然而,用于测量脆弱性的工具存在很大的差异。应该考虑使用现有或新型工具来确定脆弱性的最佳测量方法,并随后在 KT 项目中对其进行标准化测量和应用。